|
|
|||
|
|||
|
|
|||
|
haldol usual dosage cc |
|||
|
|
|||
|
|||
![]()
|
|||
|
|
|||
|
haldol usual dosage cc Manufacturer: Ortho-McNeil Prescribing Information
Haloperidol decanoate is almost insoluble in water (0.01 mg/mL), but is solublein most organic solvents haldol usual dosage cc. Each mL of HALDOL Decanoate 50 for IM injection contains 50 mg haloperidol(present as haloperidol decanoate 70.52 mg) in a sesame oil vehicle, with 1.2%(w/v) benzyl alcohol as a preservative haldol usual dosage cc. Each mL of HALDOL Decanoate 100 for IM injection contains 100 mg haloperidol(present as haloperidol decanoate 141.04 mg) in a sesame oil vehicle, with 1.2%(w/v) benzyl alcohol as a preservative haldol usual dosage cc.
Administration of haloperidol decanoate in sesame oil results in slow and sustainedrelease of haloperidol haldol usual dosage cc. The plasma concentrations of haloperidol gradually rise,reaching a peak at about 6 days after the injection, and falling thereafter,with an apparent half-life of about 3 weeks haldol usual dosage cc. Steady state plasma concentrationsare achieved after the third or fourth dose haldol usual dosage cc. The relationship between dose ofhaloperidol decanoate and plasma haloperidol concentration is roughly linearfor doses below 450 mg haldol usual dosage cc. It should be noted, however, that the pharmacokineticsof haloperidol decanoate following intramuscular injections can be quite variablebetween subjects haldol usual dosage cc.
HALDOL is contraindicated in severe toxic central nervous system depressionor comatose states from any cause and in individuals who are hypersensitiveto this drug or have Parkinson's disease haldol usual dosage cc.
Both the risk of developing tardive dyskinesia and the likelihood that it willbecome irreversible are believed to increase as the duration of treatment andthe total cumulative dose of antipsychotic drugs administered to the patientincrease haldol usual dosage cc. However, the syndrome can develop, although much less commonly, afterrelatively brief treatment periods at low doses haldol usual dosage cc. There is no known treatment for established cases of tardive dyskinesia, althoughthe syndrome may remit, partially or completely, if antipsychotic treatmentis withdrawn haldol usual dosage cc. Antipsychotic treatment, itself, however, may suppress (or partiallysuppress) the signs and symptoms of the syndrome and thereby may possibly maskthe underlying process haldol usual dosage cc. The effect that symptomatic suppression has upon thelong-term course of the syndrome is unknown haldol usual dosage cc. Given these considerations, antipsychotic drugs should be prescribed in a mannerthat is most likely to minimize the occurrence of tardive dyskinesia haldol usual dosage cc. Chronicantipsychotic treatment should generally be reserved for patients who sufferfrom a chronic illness that 1) is known to respond to antipsychotic drugs, and2) for whom alternative, equally effective, but potentially less harmful treatmentsare not available or appropriate haldol usual dosage cc. In patients who do require chronic treatment,the smallest dose and the shortest duration of treatment producing a satisfactoryclinical response should be sought haldol usual dosage cc. The need for continued treatment shouldbe reassessed periodically haldol usual dosage cc. If signs and symptoms of tardive dyskinesia appear in a patient on antipsychotics,drug discontinuation should be considered haldol usual dosage cc. However, some patients may requiretreatment despite the presence of the syndrome haldol usual dosage cc. (For further information aboutthe description of tardive dyskinesia and its clinical detection, please referto ADVERSE REACTIONS .) Neuroleptic Malignant Syndrome (NMS)-- A potentially fatal symptom complexsometimes referred to as Neuroleptic Malignant Syndrome (NMS) has been reportedin association with antipsychotic drugs haldol usual dosage cc. Clinical manifestations of NMS arehyperpyrexia, muscle rigidity, altered mental status (including catatonic signs)and evidence of autonomic instability (irregular pulse or blood pressure, tachycardia,diaphoresis, and cardiac dysrhythmias) haldol usual dosage cc. Additional signs may include elevatedcreatine phosphokinase, myoglobinuria (rhabdomyolysis) and acute renal failure haldol usual dosage cc. The diagnostic evaluation of patients with this syndrome is complicated haldol usual dosage cc. Inarriving at a diagnosis, it is important to identify cases where the clinicalpresentation includes both serious medical illness (e.g., pneumonia, systemicinfection, etc.) and untreated or inadequately treated extrapyramidal signsand symptoms (EPS) haldol usual dosage cc. Other important considerations in the differential diagnosisinclude central anticholinergic toxicity, heat stroke, drug fever and primarycentral nervous system (CNS) pathology haldol usual dosage cc. The management of NMS should include 1) immediate discontinuation of antipsychoticdrugs and other drugs not essential to concurrent therapy, 2) intensive symptomatictreatment and medical monitoring, and 3) treatment of any concomitant seriousmedical problems for which specific treatments are available haldol usual dosage cc. There is no generalagreement about specific pharmacological treatment regimens for uncomplicatedNMS haldol usual dosage cc. If a patient requires antipsychotic drug treatment after recovery from NMS,the potential reintroduction of drug therapy should be carefully considered haldol usual dosage cc. The patient should be carefully monitored, since recurrences of NMS have beenreported haldol usual dosage cc. Hyperpyrexia and heat stroke, not associated with the above symptom complex,have also been reported with HALDOL haldol usual dosage cc. General-- A number of cases of bronchopneumonia, some fatal, have followedthe use of antipsychotic drugs, including HALDOL (haloperidol) haldol usual dosage cc. It has beenpostulated that lethargy and decreased sensation of thirst due to central inhibitionmay lead to dehydration, hemoconcentration and reduced pulmonary ventilation haldol usual dosage cc. Therefore, if the above signs and symptoms appear, especially in the elderly,the physician should institute remedial therapy promptly haldol usual dosage cc. Although not reported with HALDOL, decreased serum cholesterol and/or cutaneousand ocular changes have been reported in patients receiving chemically-relateddrugs haldol usual dosage cc.
If concomitant antiparkinson medication is required, it may have to be continuedafter HALDOL Decanoate 50 or HALDOL Decanoate 100 is discontinued because ofthe prolonged action of haloperidol decanoate haldol usual dosage cc. If both drugs are discontinuedsimultaneously, extrapyramidal symptoms may occur haldol usual dosage cc. The physician should keepin mind the possible increase in intraocular pressure when anticholinergic drugs,including antiparkinson agents, are administered concomitantly with haloperidoldecanoate haldol usual dosage cc. In patients with thyrotoxicosis who are also receiving antipsychotic medication,including haloperidol decanoate, severe neurotoxicity (rigidity, inability towalk or talk) may occur haldol usual dosage cc. When HALDOL is used to control mania in bipolar disorders, there may be a rapidmood swing to depression haldol usual dosage cc. Information for Patients The use of alcohol with this drug should be avoided due to possible additiveeffects and hypotension haldol usual dosage cc. |
|||
![]()
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
| hhaldol usual dosage cc haaldol usual dosage cc halldol usual dosage cc halddol usual dosage cc haldool usual dosage cc haldoll usual dosage cc haldol usual dosage cc haldol uusual dosage cc haldol ussual dosage cc haldol usuual dosage cc haldol usuaal dosage cc haldol usuall dosage cc haldol usual dosage cc haldol usual ddosage cc haldol usual doosage cc haldol usual dossage cc haldol usual dosaage cc haldol usual dosagge cc haldol usual dosagee cc haldol usual dosage cc haldol usual dosage ccc haldol usual dosage ccc aldol usual dosage cc hldol usual dosage cc hadol usual dosage cc halol usual dosage cc haldl usual dosage cc haldo usual dosage cc haldolusual dosage cc haldol sual dosage cc haldol uual dosage cc haldol usal dosage cc haldol usul dosage cc haldol usua dosage cc haldol usualdosage cc haldol usual osage cc haldol usual dsage cc haldol usual doage cc haldol usual dosge cc haldol usual dosae cc haldol usual dosag cc haldol usual dosagecc haldol usual dosage c haldol usual dosage c h aldol usual dosage cc ha ldol usual dosage cc hal dol usual dosage cc hald ol usual dosage cc haldo l usual dosage cc haldol usual dosage cc haldol usual dosage cc haldol u sual dosage cc haldol us ual dosage cc haldol usu al dosage cc haldol usua l dosage cc haldol usual dosage cc haldol usual dosage cc haldol usual d osage cc haldol usual do sage cc haldol usual dos age cc haldol usual dosa ge cc haldol usual dosag e cc haldol usual dosage cc haldol usual dosage cc haldol usual dosage c c haldol usual dosage cc ahldol usual dosage cc hladol usual dosage cc hadlol usual dosage cc halodl usual dosage cc haldlo usual dosage cc haldo lusual dosage cc haldolu sual dosage cc haldol suual dosage cc haldol uusal dosage cc haldol usaul dosage cc haldol usula dosage cc haldol usua ldosage cc haldol usuald osage cc haldol usual odsage cc haldol usual dsoage cc haldol usual doasge cc haldol usual dosgae cc haldol usual dosaeg cc haldol usual dosag ecc haldol usual dosagec c haldol usual dosage cc ahaldol usual dosage cc thehaldol usual dosage cc haldol usual dosage cc | |||
|
|
|||
|
|
|||
|
|
|||
|
Copyright 2005 D-S LTD. |